other material
confidence high
sentiment negative
materiality 0.75
INVO Bioscience enters $850K equity purchase agreement with Triton Funds, issues warrants at $2.00/share
INVO Fertility, Inc.
- Up to 1,000,000 shares at $0.85/share sold to Triton, aggregate proceeds capped at $850,000.
- Private placement warrants for 1,000,000 shares at $2.00/share, immediately exercisable, expire in 5 years.
- Purchase agreement expires Dec 31, 2024; Triton obligated to buy on Company's request but no shorting allowed.
- Until shareholder approval, shares issued limited to 523,344 (19.9% of outstanding common stock) under Nasdaq rules.
- Proceeds used for general corporate purposes; warrants unregistered and no trading market expected.